oleic acid has been researched along with Diabetic Nephropathies in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, L; Cheng, F; Guo, Y; Li, J; Yang, K; Zhang, N | 1 |
| Kang, BC; Lee, E; Lee, HS; Suh, JY | 1 |
| Ha, H; Natarajan, R; Park, J; Park, JH; Song, KH | 1 |
| Downton, M; Du, Y; Jia, Z; Liu, G; Liu, S; Liu, Y; Yang, T | 1 |
| Chuang, PY; He, JC; Menon, MC | 1 |
| Araki, H; Araki, S; Chin-Kanasaki, M; Haneda, M; Isshiki, K; Kashiwagi, A; Koya, D; Kume, S; Maegawa, H; Morita, Y; Tanaka, Y; Uzu, T; Yasuda, M | 1 |
6 other study(ies) available for oleic acid and Diabetic Nephropathies
| Article | Year |
|---|---|
Material basis and action mechanism of Euryale Ferox Salisb in preventing and treating diabetic kidney disease.
Topics: Antioxidants; Apoptosis; Diabetes Mellitus; Diabetic Nephropathies; Humans; Molecular Docking Simulation; Oleic Acid | 2022 |
Lipotoxicity dysregulates the immunoproteasome in podocytes and kidneys in type 2 diabetes.
Topics: Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Eicosapentaenoic Acid; Glucose; Hydrogen Peroxide; Kidney; Mice; Oleic Acid; Oxidative Stress; Podocytes | 2021 |
Fractalkine and its receptor mediate extracellular matrix accumulation in diabetic nephropathy in mice.
Topics: Animals; Cells, Cultured; Chemokine CX3CL1; CX3C Chemokine Receptor 1; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Extracellular Matrix; Glucose; Male; Mice; Mice, Knockout; Mice, Transgenic; Oleic Acid; Receptors, Chemokine; Transforming Growth Factor beta1 | 2013 |
Combined losartan and nitro-oleic acid remarkably improves diabetic nephropathy in mice.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Drug Therapy, Combination; Humans; Losartan; Mice; Mice, Inbred C57BL; Oleic Acid; Renin-Angiotensin System | 2013 |
Nitro-oleic acid is a novel anti-oxidative therapy for diabetic kidney disease.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Diabetic Nephropathies; Humans; Losartan; Oleic Acid | 2013 |
Fatty acids are novel nutrient factors to regulate mTORC1 lysosomal localization and apoptosis in podocytes.
Topics: Animals; Apoptosis; Cell Line; Diabetic Nephropathies; Eicosapentaenoic Acid; Endoplasmic Reticulum Stress; Fatty Acids; Food; HEK293 Cells; Humans; Lysosomes; Mechanistic Target of Rapamycin Complex 1; Mice; Multiprotein Complexes; Oleic Acid; Palmitates; Podocytes; TOR Serine-Threonine Kinases | 2014 |